Predictors of Response to Iron and Erythropoietin Stimulating Agents
Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to identify predictors of treatment response. This involves
collected baseline clinical parameters and bloods for biochemical parameters prior to
administering the study treatment. A positive outcome following treatment was defined as an
uptitration of haemoglobin by greater than 5g/l within 2 months. The study evaluated the
participants response to treatment against the clinical and biochemical information collected
prior to treatment being received.